tiprankstipranks

Robert Bitterman Insider Profile

4 Followers
Robert Bitterman, Chairman, Pres & CEO, Director at Phio Pharmaceuticals, holds 17.83K shares in Phio Pharmaceuticals (Ticker: PHIO), holds 0.00 shares in Fibrocell Science (Ticker: FCSC).
tipranks
Robert Bitterman

Robert Bitterman
Phio Pharmaceuticals (PHIO)
Chairman, Pres & CEO, Director

Ranked #97,085 out of 99,797 Corporate Insiders

Profitable Transactions

0%
0 out of 10 Profitable Transactions

Average Return

-72.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$31K
100.00%
A breakdown of Robert Bitterman's holdings

Insider Roles

Phio Pharmaceuticals
(PHIO)
Chairman, Pres & CEO, Director
Roles that Robert Bitterman holds in companies

Most Profitable Insider Trade

Stock:
Phio Pharmaceuticals
(PHIO)
Rating:Informative Buy
Date:Jun 11, 2024 - Today
Return:-57.90%
The most profitable trade made by Robert Bitterman

Robert Bitterman's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Phio Pharmaceuticals
Sep 13, 2024
Chairman, Pres & CEO, Director
Uninformative Buy
$31.38K
FCSC
Fibrocell Science
$0.00
List of latest transactions for each holding click on a transaction to see Robert Bitterman's performance on stock

Robert Bitterman insider profile FAQ

What is the percentage of profitable transactions made by Robert Bitterman?
The percentage of profitable transactions made by Robert Bitterman is 0%.
    What is the average return per transaction made by Robert Bitterman?
    The average return per transaction made by Robert Bitterman is -72.70%.
      What stocks does Robert Bitterman hold?
      Robert Bitterman holds: PHIO, FCSC stocks.
        What was Robert Bitterman’s latest transaction?
        Robert Bitterman latest transaction was an Uninformative Buy of ―.
          What was Robert Bitterman's most profitable transaction?
          Robert Bitterman’s most profitable transaction was an Informative Buy of PHIO stock on June 11, 2024. The return on the trade was -57.90%.
            What is Robert Bitterman's role in Phio Pharmaceuticals?
            Robert Bitterman's role in Phio Pharmaceuticals is Chairman, Pres & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.